Department of Surgery, Osaka University, Yamadaoka 2-2(E2), Suita, Osaka 565-0871, Japan.
Surg Endosc. 2013 Feb;27(2):610-7. doi: 10.1007/s00464-012-2499-6. Epub 2012 Aug 31.
This study was designed to evaluate the surgical parameters and treatment outcomes of tumor hemodynamics-based pure laparoscopic (PURE) and laparoscopy-assisted (HYBRID) hepatectomy for small hepatocellular carcinoma (HCC) compared with those of open hepatectomy.
Using a prospectively collected database from 1997 to 2011, we analyzed the data of 56 consecutive cases of laparoscopic hepatectomy for HCC (PURE, n = 24; HYBRID, n = 29; HALS, n = 3) from among 102 cases undergoing laparoscopic hepatectomy. We employed 27 cases treated by open hepatectomy during the same period as controls.
PURE was associated with lesser blood loss, lower weight of the resected liver, and a shorter skin incision than HYBRID and open hepatectomy [median blood loss (mL): PURE 7, HYBRID 380, Open 450; P < 0.05]. On the other hand, HYBRID hepatectomy was associated with a longer operation time [operation time (min): HYBRID 232, Open 185; P = 0.0226]. The length of hospitalization in the cases treated by PURE and HYBRID hepatectomy was shorter than that in the cases treated by open hepatectomy [length of hospitalization (days): PURE 11, HYBRID 12, Open 17; P < 0.05]. One case each of transfusion and morbidity was recorded in this series. There was no significant difference of the overall (OS) or disease-free survival (DFS) between the patients treated by laparoscopic and open hepatectomy (3-year OS: 100 vs. 100 %; DFS 50 vs. 62 %, respectively).
Neither the surgical parameters nor the treatment outcomes of hemodynamics-based laparoscopic hepatectomy were inferior to those of open hepatectomy.
本研究旨在评估基于肿瘤血液动力学的单纯腹腔镜(PURE)和腹腔镜辅助(HYBRID)肝切除术与开腹肝切除术治疗小肝细胞癌(HCC)的手术参数和治疗效果。
使用 1997 年至 2011 年前瞻性收集的数据库,我们分析了 102 例腹腔镜肝切除术治疗 HCC 中 56 例连续病例的资料(PURE,n=24;HYBRID,n=29;HALS,n=3)。我们将同期 27 例开腹肝切除术作为对照。
与 HYBRID 和开腹肝切除术相比,PURE 出血量更少,切除肝脏的重量更轻,皮肤切口更短[中位数出血量(mL):PURE 7,HYBRID 380,开腹 450;P<0.05]。另一方面,HYBRID 肝切除术的手术时间更长[手术时间(min):HYBRID 232,开腹 185;P=0.0226]。PURE 和 HYBRID 肝切除术治疗的病例住院时间短于开腹肝切除术治疗的病例[住院时间(天):PURE 11,HYBRID 12,开腹 17;P<0.05]。本系列中各有 1 例输血和并发症病例。腹腔镜和开腹肝切除术治疗的患者总体(OS)或无病生存率(DFS)无显著差异(3 年 OS:100%比 100%;DFS 50%比 62%)。
基于血液动力学的腹腔镜肝切除术的手术参数和治疗效果并不逊于开腹肝切除术。